A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab (BMS-936558, anti-PD-1 Monoclonal Antibody) in Advanced Cancers

Project: Research

Project Details

NMA Reference Number: HREC/16/MH/14
SSA Reference Number: SSA/16/MonH/373
Monash Health HREC Ref: RES-16-0000557X

Status	Active
Effective start/end date	29/01/19 → 28/01/24